Research progress of biliary tract infection after interventional treatment of malignant obstructive jaundice

ZHUANG Leyi; LI Jipin; ZHANG Wenkai; SUN Yihua; HE Dong; WANG Xiang

doi:10.7619/jcmp.20222602

Journal of Clinical Medicine in Practice > 2022 > 26(22): 128-131, 138. > DOI: 10.7619/jcmp.20222602

ZHUANG Leyi, LI Jipin, ZHANG Wenkai, SUN Yihua, HE Dong, WANG Xiang. Research progress of biliary tract infection after interventional treatment of malignant obstructive jaundice[J]. Journal of Clinical Medicine in Practice, 2022, 26(22): 128-131, 138. DOI: 10.7619/jcmp.20222602

Citation:

PDF (666 KB)

Research progress of biliary tract infection after interventional treatment of malignant obstructive jaundice

1.
the Second Clinical Medical College of Lanzhou University, Lanzhou, Gansu, 730000
2.
Department of Gastroenterology, the Second Hospital of Lanzhou University, Lanzhou, Gansu, 730000

More Information

Received Date: August 21, 2022
Available Online: November 17, 2022

Graphical Abstract

Abstract

Abstract

Malignant obstructive jaundice is mostly caused by biliopancreatic malignant tumors, mainly manifested as hepatic dysfunction and cholestasis. Treatment methods includes endoscopic retrograde cholangiopancreatography (ERCP) stent implantation, percutaneous transhepatic cholangial drainage (PTCD), endoscopic nose biliary drainage(ENBD) and other interventional operations. Biliary tract infection is one of serious complications after interventional treatment of malignant obstructive jaundice, and can cause septic shock and threaten the life of the patients. By summarizing the risk factors, causes, pathogenic bacteria spectrum, drug resistance and antibiotic selection in recent years, this paper reviewed the research progress of biliary tract infection after interventional treatment of malignant obstructive jaundice in order to reduce the occurrence of biliary tract infection.
- malignant obstructive jaundice,
- interventional treatment,
- risk factors,
- biliary tract infection,
- research progress

FullText(HTML)

References (45)

References

[1]	BANALES J M, MARIN J J G, LAMARCA A, et al. Cholangiocarcinoma 2020: the next horizon in mechanisms and management[J]. Nat Rev Gastroenterol Hepatol, 2020, 17(9): 557-588. doi: 10.1038/s41575-020-0310-z
[2]	TSETIS D, KROKIDIS Μ, NEGRU D, et al. Malignant biliary obstruction: the current role of interventional radiology[J]. Ann Gastroenterol, 2016, 29(1): 33-36.
[3]	金龙, 邹英华. 梗阻性黄疸经皮肝穿刺胆道引流及支架植入术专家共识(2018)[J]. 临床肝胆病杂志, 2019, 35(3): 504-508. doi: 10.3969/j.issn.1001-5256.2019.03.010
[4]	SUNDARAM S, DHIR V. EUS-guided biliary drainage for malignant hilar biliary obstruction: a concise review[J]. Endosc Ultrasound, 2021, 10(3): 154-160. doi: 10.4103/EUS-D-21-00004
[5]	VAN DER MERWE S W, VAN WANROOIJ R L J, BRONSWIJK M, et al. Therapeutic endoscopic ultrasound: European society of gastrointestinal endoscopy (ESGE) guideline[J]. Endoscopy, 2022, 54(2): 185-205. doi: 10.1055/a-1717-1391
[6]	刘娟, 刘波, 李惠芬, 等. 胆道感染病原学分析[J]. 中华医院感染学杂志, 2018, 28(20): 3111-3114.
[7]	XIA M X, WANG S P, WU J, et al. The risk of acute cholangitis after endoscopic stenting for malignant hilar strictures: a large comprehensive study[J]. J Gastroenterol Hepatol, 2020, 35(7): 1150-1157. doi: 10.1111/jgh.14954
[8]	FERRAZ GONÇALVES J A, ROSENDO E, SOUSA L, et al. Complications of biliary drainage in patients with malignant biliary obstruction[J]. J Gastrointest Cancer, 2021, 52(3): 1067-1072. doi: 10.1007/s12029-020-00541-6
[9]	EVERETT B T, NAUD S, ZUBARIK R S. Risk factors for the development of stent-associated cholangitis following endoscopic biliary stent placement[J]. Dig Dis Sci, 2019, 64(8): 2300-2307. doi: 10.1007/s10620-019-05533-6
[10]	YU H, YUANYUAN S, GUO Z, et al. Multifactorial analysis of biliary infection after percutaneous transhepatic biliary drainage treatment of malignant biliary obstruction[J]. J Cancer Res Ther, 2018, 14(7): 1503-1508. doi: 10.4103/jcrt.JCRT_256_18
[11]	黄继续, 陈蓉蓉, 翁溢鑫, 等. 介入治疗梗阻性黄疸患者胆道感染的影响因素分析[J]. 中华医院感染学杂志, 2019, 29(3): 415-417, 421.
[12]	朱飚, 傅建, 朱翔宇, 等. 恶性梗阻性黄疸患者PTCD术后胆道感染病原学与影响因素[J]. 中华医院感染学杂志, 2020, 30(23): 3644-3648.
[13]	范小斌, 徐明洲, 贾亚鹏, 等. 恶性梗阻性黄疸PTCD术后胆道感染危险因素及sCD14-ST诊断价值[J]. 中华医院感染学杂志, 2021, 31(2): 233-237.
[14]	张业坡, 曹玲, 胡红杰. 经皮胆道支架植入治疗恶性胆道梗阻术后并发胆道感染相关因素临床分析[J]. 中华介入放射学电子杂志, 2021, 9(2): 171-176.
[15]	刘军, 邓登豪, 朱海杭, 等. 恶性胆道梗阻ERCP引流术后并发胆管炎原因分析[J]. 实用临床医药杂志, 2011, 15(15): 40-42, 58. doi: 10.3969/j.issn.1672-2353.2011.15.014
[16]	曾甫梅, 钱文楷, 纪安来, 等. 453例胆道感染胆汁培养阳性患者病原菌分布及影响因素、耐药性分析[J]. 实用临床医药杂志, 2021, 25(24): 92-96. doi: 10.7619/jcmp.20212996
[17]	JANG S, STEVENS T, PARSI M A, et al. Superiority of self-expandable metallic stents over plastic stents in treatment of malignant distal biliary strictures[J]. Clin Gastroenterol Hepatol, 2022, 20(2): e182-e195. doi: 10.1016/j.cgh.2020.12.020
[18]	ALMADI M A, BARKUN A, MARTEL M. Plastic vs. self-expandable metal stents for palliation in malignant biliary obstruction: a series of meta-analyses[J]. Am J Gastroenterol, 2017, 112(2): 260-273. doi: 10.1038/ajg.2016.512
[19]	JUNG J H, PARK S W, PARK S W, et al. Identification of risk factors for obstructive cholecystitis following placement of biliary stent in unresectable malignant biliary obstruction: a 5-year retrospective analysis in single center[J]. Surg Endosc, 2021, 35(6): 2679-2689. doi: 10.1007/s00464-020-07694-2
[20]	WATANABE M, OKUWAKI K, WOO J, et al. Cholecystitis after placement of covered self-expandable metallic stents in patients with distal malignant biliary obstructions[J]. Clin Endosc, 2021, 54(4): 589-595. doi: 10.5946/ce.2020.136
[21]	LIU C, XING W, SI T, et al. Should the Oddis sphincter be retained A clinical analysis of biliary metal stent implantation in patients with malignant obstructive jaundice[J]. J Cancer Res Ther, 2020, 16(5): 1119-1124. doi: 10.4103/jcrt.JCRT_220_20
[22]	SONG S, JIN H, CHENG Q, et al. Local palliative therapies for unresectable malignant biliary obstruction: radiofrequency ablation combined with stent or biliary stent alone An updated meta-analysis of nineteen trials[J]. Surg Endosc, 2022, 36(8): 5559-5570. doi: 10.1007/s00464-022-09181-2
[23]	SHA K H, LIU T G, YANG F, et al. Irradiation stent insertion for inoperable malignant biliary obstruction: a meta-analysis of randomized controlled trials[J]. Abdom Radiol: NY, 2021, 46(5): 2173-2181. doi: 10.1007/s00261-020-02851-6
[24]	CHEN W Y, KONG C L, MENG M M, et al. Percutaneous biliary stent combined with brachytherapy using ¹²⁵I seeds for treatment of unresectable malignant obstructive jaundice: a meta-analysis[J]. World J Clin Cases, 2021, 9(35): 10979-10993.
[25]	CSENDES A, FERNANDEZ M, URIBE P. Bacteriology of the gallbladder bile in normal subjects[J]. Am J Surg, 1975, 129(6): 629-631.
[26]	CHANDRASEKHARA V, KHASHAB M A, MUTHUSAMY V R, et al. Adverse events associated with ERCP[J]. Gastrointestinal Endoscopy, 2017, 85(1): 32-47.
[27]	JOHNSON K D, PERISETTI A, THARIAN B, et al. Endoscopic retrograde cholangiopancreatography-related complications and their management strategies: a "scoping" literature review[J]. Dig Dis Sci, 2020, 65(2): 361-375.
[28]	ZHAO J, WANG Q, ZHANG J. Changes in microbial profiles and antibiotic resistance patterns in patients with biliary tract infection over a six-year period[J]. Surg Infect: Larchmt, 2019, 20(6): 480-485.
[29]	SCHEUFELE F, AICHINGER L, JÄGER C, et al. Effect of preoperative biliary drainage on bacterial flora in bile of patients with periampullary cancer[J]. Br J Surg, 2017, 104(2): e182-e188.
[30]	MANRAI M, JHA A A, SINGH SHERGILL S P, et al. Microbiology of bile in extrahepatic biliary obstruction: a tropical experience[J]. Indian J Med Microbiol, 2021, 39(1): 54-58.
[31]	REUKEN P A, TORRES D, BAIER M, et al. Risk factors for multi-drug resistant pathogens and failure of empiric first-line therapy in acute cholangitis[J]. PLoS One, 2017, 12(1): e0169900.
[32]	GOMI H, SOLOMKIN J S, SCHLOSSBERG D, et al. Tokyo Guidelines 2018: antimicrobial therapy for acute cholangitis and cholecystitis[J]. J Hepatobiliary Pancreat Sci, 2018, 25(1): 3-16.
[33]	BRUNS T, STALLMACH A. Bacterial hepatobiliary infections: Pathogen spectrum, antimicrobial resistance and current treatment concepts[J]. Internist: Berl, 2022, 63(4): 349-366.
[34]	郑文灿, 黄兴富, 法艳梅, 等. 胆道感染患者临床抗感染治疗策略的研究进展[J]. 抗感染药学, 2019, 16(3): 369-371.
[35]	胡凤林, 尚东, 张浩翔, 等. 《东京指南(2018)》急性胆道感染诊疗策略更新解读[J]. 中国实用外科杂志, 2018, 38(7): 763-766.
[36]	BLENKHARN J I, HABIB N, MOK D, et al. Decreased biliary excretion of piperacillin after percutaneous relief of extrahepatic obstructive jaundice[J]. Antimicrob Agents Chemother, 1985, 28(6): 778-780.
[37]	WULKERSDORFER B, JAROS D, EBERL S, et al. Human bile reduces antimicrobial activity of selected antibiotics against Enterococcus faecalis and Escherichia coliin vitro[J]. Antimicrob Agents Chemother, 2017, 61(8): e00527-e00517.
[38]	WOBSER H, GUNESCH A, KLEBL F. Prophylaxis of post-ERC infectious complications in patients with biliary obstruction by adding antimicrobial agents into ERC contrast media-a single center retrospective study[J]. BMC Gastroenterol, 2017, 17(1): 10.
[39]	THABIT A K. Antibiotics in the biliary tract: a review of the pharmacokinetics and clinical outcomes of antibiotics penetrating the bile and gallbladder wall[J]. Pharmacotherapy, 2020, 40(7): 672-691.
[40]	DUMONCEAU J M, KAPRAL C, AABAKKEN L, et al. ERCP-related adverse events: European society of gastrointestinal endoscopy (ESGE) guideline[J]. Endoscopy, 2020, 52(2): 127-149.
[41]	KHASHAB M A, CHITHADI K V, ACOSTA R D, et al. Antibiotic prophylaxis for GI endoscopy[J]. Gastrointestinal Endoscopy, 2015, 81(1): 81-89.
[42]	DU M, SUO J, LIU B, et al. Post-ERCP infection and its epidemiological and clinical characteristics in a large Chinese tertiary hospital: a 4-year surveillance study[J]. Antimicrob Resist Infect Control, 2017, 6: 131.
[43]	ZHANG W H, DING P P, LIU L, et al. CO₂ or air cholangiography reduces the risk of post-ERCP cholangitis in patients with Bismuth type IV hilar biliary obstruction[J]. BMC Gastroenterol, 2020, 20(1): 189.
[44]	HE Q B, ZHENG R H, WANG Y, et al. Using air cholangiography to reduce postendoscopic retrograde cholangiopancreatography cholangitis in patients with malignant hilar obstruction[J]. Quant Imaging Med Surg, 2022, 12(3): 1698-1705.
[45]	TRINGALI A, LEMMERS A, MEVES V, et al. Intraductal biliopancreatic imaging: European society of gastrointestinal endoscopy (ESGE) technology review[J]. Endoscopy, 2015, 47(8): 739-753.

Cited By

Get Citation

PDF

XML

Article views (308) PDF downloads (13)

Turn off MathJax

Article Contents

Abstract

References

Research progress of biliary tract infection after interventional treatment of malignant obstructive jaundice

Abstract

References

Catalog

Export File

Citation

Format

Content